Merck Singulair Packaging Confusion
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck should modify the unit-dose packaging of Singulair (montelukast) to differentiate labeling of 4 mg, 5 mg and 10 mg strengths, The Institute for Safe Medication Practices said June 17
|
Merck should modify the unit-dose packaging of Singulair (montelukast) to differentiate labeling of 4 mg, 5 mg and 10 mg strengths, The Institute for Safe Medication Practices said June 17. "The real fix lies with the manufacturer, which should redesign the package after soliciting input from practitioners and experts," ISMP said. The organization "has contacted Merck on previous occasions to offer assistance on this regard, but to no avail." ISMP asks for practitioners to submit dosing error reports so that it can continue to discuss labeling changes with Merck. |